In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever.
@article{Capoor2007InVA,
title={In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever.},
author={Malini Capoor and Deepti Rawat and Deepthi G Nair and Azra S. Hasan and Monorama Deb and Pushpa Aggarwal and Parukutty Pillai},
journal={Journal of medical microbiology},
year={2007},
volume={56 Pt 11},
pages={
1490-4
}
}The therapeutic alternatives available for use against ciprofloxacin-resistant enteric fever isolates in an endemic area are limited. The antibiotics currently available are the quinolones, third-generation cephalosporins and conventional first-line drugs. In this study, the MICs of various newer drugs were determined for 31 ciprofloxacin-resistant enteric fever isolates (26 Salmonella enterica serovar Typhi and 5 S. enterica serovar Paratyphi A). MICs for ciprofloxacin, ofloxacin, gatifloxacin…
56 Citations
Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella spp.
- Biology, MedicineJournal of medical microbiology
- 2009
Tigecycline and the carbapenems are likely to have roles in the final stage of treatment of quinolone-resistant and ESBL-producing multidrug-resistant salmonellae.
In vitro susceptibility of some antimicrobials against bacteria enteropathogens
- Medicine, Biology
- 2011
Rifaximin is a promising treatment and chemophylaxis for nonsystemic bacteria diarrhea and resistance rates of enteropathogens were much higher in this area of China than other regions or countries.
Minimum inhibitory concentration (MIC) of Ceftriaxone and Azithromycin for blood culture isolates of Salmonella enterica spp.
- Medicine, BiologyJournal of infection in developing countries
- 2021
This study documents an alarming increase in resistance to ceftriaxone among NARS in Mumbai while azithromycin continues to be susceptible in vitro.
Azithromycin Resistance in Clinical Isolates of Salmonella enterica Serovars Typhi and Paratyphi in Bangladesh.
- Medicine, BiologyMicrobial drug resistance
- 2019
The occurrence of macrolide resistance in clinical Salmonella enterica serovars Typhi and Paratyphi is of particular significance in Bangladesh where azithromycin is a commonly used drug against most diseases.
Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections
- Medicine, BiologyClinical Microbiology Reviews
- 2015
Azithromycin is effective for the management of uncomplicated typhoid fever and may serve as an alternative oral drug in areas where fluoroquinolone resistance is common and ciprofloxacin susceptibility breakpoints were lowered to account for accumulating clinical, microbiologic, and pharmacokinetic-pharmacodynamic data.
Patterns in antimicrobial susceptibility of Salmonellae isolated at a tertiary care hospital in northern India
- Medicine, BiologyThe Indian journal of medical research
- 2017
This study showed an alarming increase in MIC to quinolones and re-emergence of susceptibility to conventional antibiotics among Salmonellae.
Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India
- Medicine, BiologyTropical doctor
- 2018
Though mortality and relapse in the authors' cohort was low, NARST seemed to correlate with mortality, and Gatifloxacin or azithromycin clearly emerge as the drugs of choice for treatment of typhoid in South India.
Increasing antimicrobial resistance and narrowing therapeutics in typhoidal salmonellae.
- Medicine, BiologyJournal of clinical and diagnostic research : JCDR
- 2013
Increasing resistance to fluoroquinolones in typhoidal Salmonellae is alarming and emphasizes the need of effective preventive measures to control typhoid and to limit the unnecessary use of antibiotics.
Increasing antimicrobial resistance and narrowing therapeutics in typhoidal salmonellae.
- Medicine, Biology
- 2013
Increasing resistance to fluoroquinolones in typhoidal Salmonellae is alarming and emphasizes the need of effective preventive measures to control typhoid and to limit the unnecessary use of antibiotics.
Antimicrobial resistance in Salmonella enterica serovar typhi and paratyphi in South Asia-current status, issues and prospects
- Medicine, BiologyCritical reviews in microbiology
- 2015
Conclusively, the MDR will continue to grow and the available antimicrobial agents would become obsolete, therefore, a radical and aggressive approach in terms of rational use of antibiotics during treating infections is essentially needed.
References
SHOWING 1-10 OF 16 REFERENCES
High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India.
- Medicine, BiologyJournal of medical microbiology
- 2005
To the authors' knowledge there have been no reports of absolute resistance to ciprofloxacin in S. enterica serotype Typhi (S. Typhi), but recently there has been a report of the isolation of a strain of SalmonellaEnteric fever serotype Paratyphi A showing resistance tociproFLoxacIn.
In vitro activity of azithromycin against bacterial enteric pathogens
- Medicine, BiologyAntimicrobial Agents and Chemotherapy
- 1993
The high intracellular concentrations achieved by azithromycin may be particularly relevant for organisms like S. typhi, Campylobacter spp.
Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives.
- Medicine, BiologyInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
- 2006
Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India.
- Medicine, BiologyJournal of medical microbiology
- 2007
The isolation of five clinical strains of S. Typhi from HIV-infected patients that were also resistant to ciprofloxacin, another quinolone derivative is described.
Randomized Controlled Comparison of Ofloxacin, Azithromycin, and an Ofloxacin-Azithromycin Combination for Treatment of Multidrug-Resistant and Nalidixic Acid-Resistant Typhoid Fever
- Medicine, BiologyAntimicrobial Agents and Chemotherapy
- 2006
Uncomplicated typhoid fever due to isolates of MDR S. enterica serovar Typhi with reduced susceptibility to fluoroquinolones (Nar) can be successfully treated with a 7-day course of azithromycin.
Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
- Biology, MedicineThe Journal of antimicrobial chemotherapy
- 2006
PFGE revealed undistinguishable XbaI fragment patterns in ciprofloxacin-resistant S. Typhi as well as in S. Paratyphi A isolates and showed that cipprofloxACin- resistant S. typhi have emerged from a clonally related isolate with reduced susceptibility to ciproprofl oxacin after sequential acquisition of a second mutation in gyrA.
Azithromycin versus Ciprofloxacin for Treatment of Uncomplicated Typhoid Fever in a Randomized Trial in Egypt That Included Patients with Multidrug Resistance
- Medicine, BiologyAntimicrobial Agents and Chemotherapy
- 1999
It is indicated that azithromycin and ciprofloxacin were similarly effective, both clinically and bacteriologically, against typhoid fever caused by both sensitive organisms and MDRS.
The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam.
- Medicine, BiologyTransactions of the Royal Society of Tropical Medicine and Hygiene
- 2004
Typhoid fever: narrowing therapeutic options in India.
- Medicine, BiologyThe Southeast Asian journal of tropical medicine and public health
- 2006
The molecular basis of resistance to cephalosporinsand ciprofloxacin resistance in NASST strains need to be further evaluated for S. Typhi.
Molecular Basis of Resistance Displayed by Highly Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Bangladesh
- BiologyJournal of Clinical Microbiology
- 2006
Highly ciprofloxacin-resistant strains of Salmonella enterica serovar Typhi were isolated from the blood of typhoid patients in Dhaka, Bangladesh and had matching point mutations at positions 83 and 87 of the gyrA gene.



